October 18, 2016 / 11:22 AM / 9 months ago

BRIEF-True North Therapeutics announces $45 mln series D financing

1 Min Read

Oct 18 (Reuters) - True North Therapeutics Inc:

* True North Therapeutics announces $45 million series D financing

* True North Therapeutics - proceeds to be used to accelerate development of lead complement inhibitor, TNT009, rare diseases targeting complement system Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below